This workshop features industry professionals from Biogen who will introduce careers at and away from the bench or clinic. Participants will learn about differences in key questions for advancing research in academia vs. industry. Topics include biomarkers, regulatory, clinical development, clinical technologies, preclinical research, and talent acquisition/hiring.

REGISTER by Sept. 28 to indicate you will attend. Please let us know if your plans change. Some registrants have not received our communication with the Zoom link, so we are posting it here:

Topic: Translating Biomedical Discoveries – Biogen Cornell workshop2020
Time: 10am-1pm October 1 & 2

Join Zoom Meeting
https://cornell.zoom.us/j/91873716891?pwd=My9PZTV2SVhRRWh0Wm5XMWkwTTVRdz09

Meeting ID: 918 7371 6891
Passcode: 050299

Biogen Professionals will:

• share a brief overview of their career path and what they each contribute to a team setting
• offer case studies to highlight how the topic advances drug development
• answer questions regarding skills needed to be successful in the role

Translating Biomedical Discoveries: Scientific/Clinical Careers in Industry and Opportunities to Maximize Collaborations

• Date: October 1^st and 2^nd  ​(maximum benefit by attending both days)
• Time: 10 AM to 1 PM EST​ both days
• Target Audience: Cornell graduate students, postdoctoral and clinical fellows, and faculty in biomedical and related departments ​including Ithaca, Geneva, Cornell Tech and Weill Medical campuses
• Registration: required by Sept.28 (registration link)

​Please email Susi Varvayanis gradcareers@cornell.edu in the Careers Beyond Academia graduate school office with questions or for more information. This is not a seminar, but rather a hands-on experiential learning opportunity, so be prepared to be engaged and have your questions answered.

Program details (updates in progress):

Thursday, October 1, 2020

Welcome and program overview: 10:00 AM– 10:05 AM

Clinical technologies (scientist vs physician): 10:05 AM – 10:50 AM

Viet Nguyen, Associate Medical Director, Digital & Quantitative Medicine and Evan Remington, Scientist, Digital & Quantitative Medicine

 Biomarkers (research/early vs late development): 10:50 AM – 11:35 AM

Gersham Dent, Senior Director, Development Imaging Biomarkers, R&D , and Karl Evans, Director, Early Clinical Imaging Biomarkers, R&D

Keynote: 11:35 AM – 12:05 PM

Aaron Deykin, Senior Vice President – Clinical Sciences

12:05 PM – 12:15 PM Break

Preclinical research (pharmacology vs protein engineering):12:15 PM – 1:00 PM

Tom Cameron, Director and Head, Protein & Cell Engineering, Biologics Drug Discovery and Alex Pellerin, Scientist II, Multiple Sclerosis Research

Friday, October 2, 2020

Opening Remarks 10:00 AM – 10:05 AM

     Emmanuel Giannelis, Vice Provost and Vice President for Technology Transfer, Intellectual Property, and Research Policy at Cornell University

Clinical development (medical affairs vs R&D): 10:05 AM – 10:50 AM

Vanessa Beynon, Medical Director, Clinical Development, Multiple Sclerosis (MS), and Maria Naylor, Global Medical Lead, Interferons and MS Pipeline

Regulatory (manufacturing vs clinical): 10:50 AM – 11:35 AM

Runda Badwan, Director, Regulatory Affairs and Kim Wolfram, Director, Global Regulatory Affairs CMC

11:35 AM – 11:45 AM Break

Hiring (scientist vs physician roles): 11:45 AM – 12:30 PM

Nina McKinnon, Senior Sourcing Partner, Talent Acquisition and Lydea Monahan, Recruiting Partner, Talent Acquisition

Program recap, Cornellian perspective, closing remarks, and next steps:12:30 PM – 1:00 PM

     Cherié Butts, Medical Director and Head of Clinical Assessments – Digital & Quantitative Medicine

Background reading:

Safer, more effective medicine calls for disruptive biomedical innovation by Avery August and Cherié Butts (2017) The Hill
A novel target for accelerating drug development: Biomedical science training by Cherié Butts and Avery August (2018) Science
Drug Development Conference